Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial
BIND-014(一种靶向前列腺特异性膜抗原的多西他赛纳米颗粒)治疗转移性去势抵抗性前列腺癌患者的安全性和有效性:一项II期临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.2168
Autio, Karen A; Dreicer, Robert; Anderson, Justine; Garcia, Jorge A; Alva, Ajjai; Hart, Lowell L; Milowsky, Matthew I; Posadas, Edwin M; Ryan, Charles J; Graf, Ryon P; Dittamore, Ryan; Schreiber, Nicole A; Summa, Jason M; Youssoufian, Hagop; Morris, Michael J; Scher, Howard I